Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration-Reference-Cited by-同舟云学术

Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration

Published:2017-10-20 Issue:12 Volume:16 Page:2677-2688
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Zhao Genshi,Green Colin F.,Hui Yu-Hua,Prieto Lourdes,Shepard Robert,Dong Sucai,Wang Tao,Tan Bo,Gong Xueqian,Kays Lisa,Johnson Robert L.,Wu Wenjuan,Bhattachar Shobha,Del Prado Miriam,Gillig James R.,Fernandez Maria-Carmen,Roth Ken D.,Buchanan Sean,Kuo Ming-Shang,Geeganage Sandaruwan,Burkholder Timothy P.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxygen-Dependent Interactions between the Ruthenium Cage and the Photoreleased Inhibitor in NAMPT-Targeted Photoactivated Chemotherapy;Journal of Medicinal Chemistry;2024-06-26

2. NAMPT-targeting PROTAC and nicotinic acid co-administration elicit safe and robust anti-tumor efficacy in NAPRT-deficient pan-cancers;Cell Chemical Biology;2024-06

3. Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia;Blood Advances;2024-03-27

4. Inhibitors of NAD+ Production in Cancer Treatment: State of the Art and Perspectives;International Journal of Molecular Sciences;2024-02-08

5. Drug discovery targeting nicotinamide phosphoribosyltransferase (NAMPT): Updated progress and perspectives;Bioorganic & Medicinal Chemistry;2024-02